# Endocan and Copeptin Serum Levels in Preterm Neonates With Respiratory Distress Syndrome

> **NCT07154134** · — · RECRUITING · sponsor: **Tanta University** · enrollment: 40 (estimated)

## Conditions studied

- Endocan
- Copeptin
- Serum
- Preterm Neonates
- Respiratory Distress Syndrome

## Interventions

- **DIAGNOSTIC_TEST:** Serum endocan
- **DIAGNOSTIC_TEST:** Serum copeptin

## Key facts

- **NCT ID:** NCT07154134
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-10
- **Primary completion:** 2025-11-01
- **Final completion:** 2025-11-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07154134

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07154134, "Endocan and Copeptin Serum Levels in Preterm Neonates With Respiratory Distress Syndrome". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07154134. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*